NCT03596814View on ClinicalTrials.gov

MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II

CompletedOBSERVATIONAL
Enrollment

2,072

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Hemophilia
Interventions
OTHER

No Interventional study

Retrospective data

Trial Locations (7)

14033

Caen university Hospital, Caen

29609

Brest University Hospital, Brest

35033

Rennes University Hospital, Rennes

37044

Tours University Hospital, Tours

44093

Nantes University Hospital, Nantes

49933

Angers University Hospital, Angers

72037

Le Mans University Hospital, Le Mans

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03596814 - MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II | Biotech Hunter | Biotech Hunter